Ausgabe 5/2024
Inhalt (37 Artikel)
After one year of ChatGPT’s launch: reflections on artificial intelligence in scientific writing
Yuan Feng, Jinquan Han, Xiaoli Lan
Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer
Fabio Volpe, Leandra Piscopo, Emilia Zampella, Michele Klain
Beyond stillness: the importance of tackling patient’s motion for reliable parametric imaging
Alessia Artesani, Laura Providência, Joyce van Sluis, Charalampos Tsoumpas
Letter to the Editor: FDG Liver Biodistribution
Dale L. Bailey, Geoffrey P. Schembri, Kathy P. Willowson, Paul J. Roach
Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm
Achraf Bahloul, Antoine Verger, Yechiel Lamash, Nathaniel Roth, Diawad Dari, Pierre-Yves Marie, Laetitia Imbert
[177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models
Ziqing Zeng, Liqiang Li, Jinping Tao, Jiayue Liu, Hongjun Li, Xueming Qian, Zhi Yang, Hua Zhu
Adhesion molecule–targeted magnetic particle imaging nanoprobe for visualization of inflammation in acute lung injury
Pengli Gao, Yu Liu, Xiaoli Wang, Xin Feng, Heng Liu, Songlu Liu, Xiazi Huang, Xiangjun Wu, Fei Xiong, Xiaohua Jia, Hui Hui, Jingying Jiang, Jie Tian
Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
Qi Yang, Zhao Chen, Yongkang Qiu, Wenpeng Huang, Tianyao Wang, Lele Song, Xinyao Sun, Cuicui Li, Xiaojie Xu, Lei Kang
Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance
Andres A. Kohan, Mathieu Lupien, David Cescon, Geneviève Deblois, Manuela Ventura, Ur Metser, Patrick Veit-Haibach
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix M. Mottaghy, Jonathan Gear
FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis
Bonnia Liu, Ronald Ma, Evonne Shum, Maria Hormiz, Sze-Ting Lee, Aurora M. T. Poon, Andrew M. Scott
[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
Bastien Allard, Valérie Devauchelle-Pensec, Alain Saraux, Emmanuel Nowak, Alice Tison, Sara Boukhlal, Dewi Guellec, Sandrine Jousse-Joulin, Divi Cornec, Thierry Marhadour, Romain Le Pennec, Pierre-Yves Salaün, Solène Querellou
High-temporal resolution functional PET/MRI reveals coupling between human metabolic and hemodynamic brain response
Andreas Hahn, Murray B. Reed, Chrysoula Vraka, Godber M. Godbersen, Sebastian Klug, Arkadiusz Komorowski, Pia Falb, Lukas Nics, Tatjana Traub-Weidinger, Marcus Hacker, Rupert Lanzenberger
Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice
Yuliya Piatkova, Matthieu Doyen, Sébastien Heyer, Ayaz Tahmazov, Solene Frismand, Lucie Hopes, Laetitia Imbert, Antoine Verger
Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance
Thomas Budenkotte, Ivayla Apostolova, Roland Opfer, Julia Krüger, Susanne Klutmann, Ralph Buchert
Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded
Giorgio Treglia, Alessio Rizzo, Arnoldo Piccardo
Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease
Aymeric Boucher, Julia Delabie, Charlotte Lussey-Lepoutre, Magalie Haissaguerre, Eric Ouvrard, Vija Lavinia, Maëlle Le Bras, Marie Batisse-Lignier, Thomas Cuny, Nicolas Jacquet-Francillon, Sébastien Gaujoux, Océane Molina, Alessio Imperiale, Adrien Latge, Catherine Ansquer, Antony Kelly, Françoise Borson-Chazot, Ghoufrane Tlili, Frédéric Sebag, Zeinab Hamidou, Pauline Romanet, David Taïeb
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
Conrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, Jan-Michel Heger, Beatrice Casadei, Laura Beckmann, Ken Herrmann, Franziska J. Dekorsy, Nadine Kutsch, Peter Borchmann, Stefano Fanti, Wolfgang G. Kunz, Marion Subklewe, Carsten Kobe, Pier Luigi Zinzani, Matthias Stelljes, Katrin S. Roth, Alexander Drzezga, Richard Noppeney, Kambiz Rahbar, H. Christian Reinhardt, Bastian von Tresckow, Robert Seifert, Jörn C. Albring, Viktoria Blumenberg, Andrea Farolfi, Sarah Flossdorf, Philipp Gödel, Christine Hanoun
Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics
Guobing Liu, Yimeng Shi, Xiaoguang Hou, Haojun Yu, Yan Hu, Yiqiu Zhang, Hongcheng Shi
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology
Niklas Dreher, Stefanie Hahner, Carmina T. Fuß, Wiebke Schlötelburg, Philipp E. Hartrampf, Sebastian E. Serfling, Andreas Schirbel, Samuel Samnick, Takahiro Higuchi, Alexander Weich, Constantin Lapa, Andreas Rosenwald, Andreas K. Buck, Stefan Kircher, Rudolf A. Werner
Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy
Mengshi Li, Claudia Robles-Planells, Dijie Liu, Stephen A. Graves, Gabriela Vasquez-Martinez, Gabriel Mayoral-Andrade, Dongyoul Lee, Prerna Rastogi, Brenna M. Marks, Edwin A. Sagastume, Robert M. Weiss, Sarah C. Linn-Peirano, Frances L. Johnson, Michael K. Schultz, Diana Zepeda-Orozco
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study
Ioanna Liatsou, Yingli Fu, Zhi Li, Mahmud Hasan, Xin Guo, Jing Yu, Joseph Piccolo, Allison Cartee, Hao Wang, Yong Du, Jeffrey Bryan, Kathleen Gabrielson, Dara L. Kraitchman, George Sgouros
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges
Gaia Ninatti, Rosa Maria Moresco, Martina Sollini
Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive l-[methyl-11C] methionine cohort study with two PET scanners
Weiyan Zhou, Jianbo Wen, Qi Huang, Yan Zeng, Zhirui Zhou, Yuhua Zhu, Lei Chen, Yihui Guan, Fang Xie, Dongxiao Zhuang, Tao Hua
The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation
Riccardo Mei, Thomas Pyka, Hasan Sari, Stefano Fanti, Ali Afshar-Oromieh, Roland Giger, Federico Caobelli, Axel Rominger, Ian Alberts
Comparative assessment of radiation therapy–induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy
D. Evanson, M. Griffin, S. E. O’Reilly, T. Johnson, T. Werner, E. Kothekar, P. Jahangiri, C. B. Simone 2nd, S. Swisher-McClure, S. J. Feigenberg, M.-E. Revheim, J. Zou, A. Alavi
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI
Kai Jannusch, Frederic Dietzel, Nils Martin Bruckmann, Janna Morawitz, Matthias Boschheidgen, Peter Minko, Ann-Kathrin Bittner, Svjetlana Mohrmann, Harald H. Quick, Ken Herrmann, Lale Umutlu, Gerald Antoch, Christian Rubbert, Julian Kirchner, Julian Caspers
The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today
Daniela-Elena Oprea-Lager, Steven MacLennan, Rudi Dierckx, Stefano Fanti
Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance
Levent Kabasakal, Ruştu Turkay, Bulent Onal
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance
Kaan Akcay, Ali Kibar, Onur Erdem Sahin, Muhammet Demirbilek, Gamze Beydagi, Sertac Asa, Fuad Aghazada, Turkay Toklu, Nalan Alan Selcuk, Bulent Onal, Levent Kabasakal
A convolutional neural network–based system for fully automatic segmentation of whole-body [68Ga]Ga-PSMA PET images in prostate cancer
Esmail Jafari, Amin Zarei, Habibollah Dadgar, Ahmad Keshavarz, Reyhaneh Manafi-Farid, Habib Rostami, Majid Assadi
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
Lisa Glantschnig, Alexander Dierks, Georgine Wienand, Christian H. Pfob, Ralph A. Bundschuh, Constantin Lapa, Malte Kircher
First-in-human SPECT/CT imaging of [212Pb]Pb-VMT-α-NET in a patient with metastatic neuroendocrine tumor
Enrico Michler, David Kästner, Claudia Brogsitter, Marc Pretze, Holger Hartmann, Robert Freudenberg, Michael K. Schultz, Jörg Kotzerke
Impact of patient motion on parametric PET imaging
Alessia Artesani, Joyce van Sluis, Johannes H. van Snick, Laura Providência, Walter Noordzij, Charalampos Tsoumpas
Correction to: Theranostic role of 89Zr‑ and 177Lu‑labeled aflibercept in breast cancer
Qi Yang, Zhao Chen, Yongkang Qiu, Wenpeng Huang, Tianyao Wang, Lele Song, Xinyao Sun, Cuicui Li, Xiaojie Xu, Lei Kang